Pain medicine

Continuous posterior extrathoracic fascial plane block versus continuous paravertebral block for pain management in patients with multiple rib fractures: a randomised controlled noninferiority trial

Br J AnaesthPublished Randomised controlled trial

Authors' conclusion

Posterior extrathroacic fascial plane block promoted a noninferior effect on morphine consumption at 24 h compared with paravertebral block in patients with multiple rib fractures.

Study context

Population
Trauma patients with multiple rib fractures not mechanically ventilated77.7% male
Participants
90 patients
Comparison
Continuous PEFB vs continuous paravertebral block (PVB) vs systemic analgesia
Primary endpoint
Morphine consumption
Follow-up
24 h
Methodological detailsnoninferiority, three-arm
  • Noninferiority
  • Three-arm

Primary result

As reported in the abstract

Morphine consumption at 24 h

P < 0.001

Secondary outcomes

Morphine consumption at 72 h (per-protocol) · per-protocol analysis

OutcomePEFBPVBControlβ (95% CI)P value
Rescue thoracic epidural analgesiaPEFB vs PVB · across groupsThirty percent6.7%Thirty percentP = 0.043
MEP over 72 hHigher values in PVB12.71 (2.73–22.77)P = 0.012
Morphine consumption at 72 h (per-protocol) — Higher in control; no significant difference between intervention groups
P=0.051

Pain scores during coughing

Higher during coughing in all groups (β)
3.89
Lower with significant interaction in PVB (β)
−0.58
  • P<0.0001 for coughing; P=0.010 for PVB interaction

SNIP over 72 h

Increased significantly from baseline in all groups (β)
7.2 to 14.9
  • P=0.002

Original publication

Continuous posterior extrathoracic fascial plane block versus continuous paravertebral block for pain management in patients with multiple rib fractures: a randomised controlled noninferiority trial. Br J Anaesth. Published 20 November 2025. doi:10.1016/j.bja.2025.09.058

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.